Galapagos NV

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 08 nov 2015 - 22:36

Statutaire naam Galapagos NV

Titel Galapagos builds on strong profile of filgotinib in 7 presentations at ACR 2015

Bericht Mechelen, Belgium; 8 November 2015: Galapagos NV (Euronext & NASDAQ: GLPG) announced today that it will present the full results from DARWIN 1 & 2 studies in rheumatoid arthritis, as well as other findings from research with filgotinib at the American College of Rheumatology (ACR) Annual Meeting in San Francisco, CA, from 8-10 November, 2015. Below follows an overview of all oral and poster presentations; all dates and times are in US format and Pacific time zone. Posters and slides will be posted to glpg.com on the day following the presentation session.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

201511080000000002_Galapagos bouwt aan sterke profilering van filgotinib in 7 presentaties op ACR 2015.pdf (opens in a new window)

201511080000000002_Galapagos builds on strong profile of filgotinib in 7 presentations at ACR 2015.pdf (opens in a new window)

Datum laatste update: 01 september 2024